| {"0": "Sphingolipid metabolism integrated pathway", "1": "Sphingolipid metabolism overview", "2": "Overlap between signal transduction pathways contributing to lmna laminopathies", "3": "Degradation pathway of sphingolipids including diseases", "4": "Proteasome degradation", "5": "Familial partial lipodystrophy fpld", "6": "Sphingolipid pathway", "7": "Progeriaassociated lipodystrophy", "8": "Sphingolipid metabolism in senescence", "9": "Alzheimers disease", "10": "Alzheimers disease and mirna effects", "11": "Electron transport chain oxphos system in mitochondria", "12": "Glycerophospholipid biosynthetic pathway", "13": "Mecp2 and associated rett syndrome", "14": "Disruption of postsynaptic signaling by cnv", "15": "Angiopoietinlike protein 8 regulatory pathway", "16": "Ciliopathies", "17": "Nonalcoholic fatty liver disease", "18": "Camkk2 pathway", "19": "Nuclear receptors metapathway", "20": "Circadian rhythm genes", "21": "Cholesterol metabolism with bloch and kandutschrussell pathways", "22": "Small cell lung cancer", "23": "Translation factors", "24": "1q211 copy number variation syndrome", "25": "Network map of sarscov2 signaling pathway", "26": "Joubert syndrome", "27": "Nrf2 pathway", "28": "Apoptosis modulation and signaling", "29": "Mitochondrial complex i assembly model oxphos system", "30": "Genes controlling nephrogenesis", "31": "Ciliary landscape", "32": "Type i collagen synthesis in the context of osteogenesis imperfecta", "33": "G1 to s cell cycle control", "34": "Factors and pathways affecting insulinlike growth factor igf1akt signaling", "35": "Nsp1 from sarscov2 inhibits translation initiation in the host cell", "36": "Spinal cord injury", "37": "Ebola virus infection in host", "38": "Pathogenic escherichia coli infection", "39": "Melanoma", "40": "Insulin signaling", "41": "Cell cycle", "42": "Micrornas in cardiomyocyte hypertrophy"} |